Activating #PrimaryCare #COPD Patients with #Multimorbidity (APCOM) Trial - a global-first, #MRFF/@NHMRC-sponsored pragmatic clinical trial in primary care.
Australia
Joined June 2021
- Tweets252
- Following183
- Followers51
- Likes363
Pinned Tweet
The baseline findings poster of the #APCOMTrial, presented at the 2025 @tsanz_thoracic Scientific Meeting, can be downloaded here: drive.google.com/file/d/1ml_… #COPD #multimorbidity #primaryhealthcare
Our poster on baseline findings of the @APCOMTrial is up at the @tsanz_thoracic #tsanzsrsasm2025. Please visit poster board 97 during the Poster Session at 4 15pm today. #COPD #multimorbidity #primaryhealthcare #APCOMTrial
APCOM Trial retweeted
In this article we propose that pulmonary disorders should be incorporated into a cardio–kidney–metabolic–pulmonary (#CKMP) framework. academic.oup.com/eurjhf/arti…
APCOM Trial retweeted
7 weeks until I become the first #COPD Patient to complete 7 stars of the Abbott World Marathon Majors. Celebrate with me by donating to my fundraiser for Lung Foundation Australia
sm26.grassrootz.com/lungfoun…
APCOM Trial retweeted
Clinical features that associate with mucus plug-high phenotypes of asthma and COPD DOI: 10.1183/13993003.02358-2025 @ERSpublications
APCOM Trial retweeted
Join the World COPD Day — #COPD Baton Pass step challenge to celebrate Pulmonary Rehabilitation week in the United Kingdom. June 15th-19th
Patient link
join.thestepupapp.com/GufL8X
Healthcare Professionals link
join.thestepupapp.com/NllY2S
APCOM Trial retweeted
COPD is frequently diagnosed late when the disease has already progressed. We think people with COPD deserve to have access to the right diagnostic tools to inform a timely and accurate diagnosis. Read and download the COPD Patient Charter to learn more: copdcanada.info/copd-patient…
APCOM Trial retweeted
Patient Education - Living with COPD
Assessing your COPD, Treating your COPD, Understanding your COPD, Using your Inhaler, Medications & Practical Tips. #COPD Learn more: copdcanada.info/patient-educ…
APCOM Trial retweeted
This one of the most important #COPD papers I’ve read in years, paving the way for biology-driven therapeutics. It’s a must read.
Kudos to all involved.
Excited to share this work, now out in @NatureGenet . There is no cure for #COPD. To tackle this challenge, we performed nuclear sequencing, spatial transcriptomic, and proteomic analysis of lung tissue from 141 subjects to better understand this disease. nature.com/articles/s41588-0…
APCOM Trial retweeted
If you are interested in #multimorbidity then you might want to read our new editorial just out in @bmj_latest today: lnkd.in/eNf9rQ_K
APCOM Trial retweeted
Qualitative evaluation of the #APCOMProgram found acceptance by patients, PNs and GPs: doi.org/10.1186/s12875-025-0… Funding and standards for #selfmanagement education in general practice are needed. #COPD #multimorbidity #primaryhealthcare @HassanHosseinza @MohanaSekaran @nickzwar
APCOM Trial retweeted
What is a flare-up action plan? #SpeakUpForCOPD Learn more: copdflareups.gaapp.org/what-…
APCOM Trial retweeted
After 9 years of work, our new @ATSBlueEditor paper is out, showing that in utero maternal smoke leaves lasting scars on lung health, and identifies CC16 as the first reliable biomarker of lung health across the lifespan.
#cureCOPD
atsjournals.org/doi/abs/10.1…
APCOM Trial retweeted
World COPD Day, November 19, 2025 - The goal of this year’s campaign is to emphasize that shortness of breath is a symptom that should prompt patients and healthcare providers to consider a diagnosis of COPD.
APCOM Trial retweeted
World COPD Day, November 19, 2025 - The goal of this year’s campaign is to emphasize that shortness of breath is a symptom that should prompt patients and healthcare providers to consider a diagnosis of COPD.
APCOM Trial retweeted
🆕
The skin condition #panniculitis is a rare manifestation of #alpha1. The lack of evidence makes it difficult to treat, and those affected often experience diagnostic delay and significant symptoms.
You can read more in this paper by @ReemAlluhibi from my lab.
@AlphaFriend
Proud to share the first publication from my PhD ✨!
This study - initiated from the insight of a patient living with alpha-1 panniculitis explores the lived experience of this rare and painful condition.
📌 journals.plos.org/plosone/ar…
APCOM Trial retweeted
The International Cardiovascular & Respiratory Alliance, ICRA, is a global group that I founded & co-chair with Prof M Bhutani.
We represent healthcare professionals, academics & patients from >40 countries.
To join (free) email:
[email protected]
APCOM Trial retweeted
In theory, #DPP-1 inhibitors should work any neutrophilic #airway conditions such as #COPD. The key is finding the #neutrophilic #COPD patients.
European Respiratory Review: DPP-1 inhibitors are a novel treatment targeting neutrophilic inflammation bit.ly/3XLgfol
APCOM Trial retweeted
Wonderful collaboration with Sadan Taher, @alta_schutte, @ProfHurst and @cpgale3 on this global-first systematic review: journals.sagepub.com/doi/10.… #COPD #HTN #CVD #multimorbidity #publichealth
In this review by Sameera Ansari, @ProfHurst , et al we found “limited & inconsistent evidence available for managing concomitant #COPD & #hypertension”
journals.sagepub.com/doi/10.…
APCOM Trial retweeted
The July issue of Respirology is now available online:
onlinelibrary.wiley.com/toc/…
APCOM Trial retweeted
Feeling of satisfaction completing the Gold Coast Marathon today with one of our children. I’ve now had the joy of doing an event with all four of them as well as one grandchild. Marathons are no longer about medals or times. It’s about the joy of the experience! #copd
APCOM Trial retweeted
#COPD & the Management of Cardiopulmonary Risk
dovepress.com/chronic-obstru…
